UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2017-06, Vol.28, p.iii151-iii151

2017

Volltextzugriff (PDF)

Increased Oxidized High-Density Lipoprotein/High-Density Lipoprotein–Cholesterol Ratio as a Potential Indicator of Disturbed Metabolic Health in Overweight and Obese Individuals

Laboratory medicine, 2020-01, Vol.51 (1), p.24-33

2020

Volltextzugriff (PDF)

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION

HemaSphere, 2022-06, Vol.6 (Suppl), p.724-725

2022

Volltextzugriff (PDF)

Characterisation of dietary fibre components in cereals and legumes used in Serbian diet

Food chemistry, 2013-12, Vol.141 (3), p.1624-1629

2013

Volltextzugriff (PDF)

Effects of total fibre or resistant starch-rich diets within lifestyle intervention in obese prediabetic adults

European journal of nutrition, 2016-02, Vol.55 (1), p.127-137

2016

Volltextzugriff (PDF)

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series

Curēus (Palo Alto, CA), 2021-10

2021

Volltextzugriff (PDF)

P838 Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1560-i1560

2024

Volltextzugriff (PDF)

Dietary fat intake as risk factor for the development of Diabetes: Multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD)

Diabetes care, 2003-02, Vol.26 (2), p.302-307

2003

Volltextzugriff (PDF)

Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trial

European neuropsychopharmacology, 2014-12, Vol.24 (12), p.1861-1872

2014

Volltextzugriff (PDF)

P497 Is mucosal healing sufficient paramater for anti-TNF discontinuation?

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S433-S434

2020

Volltextzugriff (PDF)

P957 Subcutaneous infliximab (CT-P13 SC) for ulcerative colitis: 2-year extension results of the LIBERTY-UC study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1737-i1738

2024

Volltextzugriff (PDF)

P492 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i623-i624

2023

Volltextzugriff (PDF)

ESTUDOS EM ANDAMENTO FASE IB E IIA: CROSSWALK-A E CROSSWALK-C, RANDOMIZADOS E CONTROLADOS POR PLACEBO - CROVALIMABE NO TRATAMENTO E PREVENÇÃO DE EPISÓDIOS VASO-OCLUSIVOS NA DOENÇA FALCIFORME

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S75-S76

2023

Volltextzugriff (PDF)

POS-052 TWO PHASE III TRIALS EVALUATING CROVALIMAB IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): COMMUTE-a and COMMUTE-p

Kidney international reports, 2022-06, Vol.7 (6), p.S460-S461

2022

Volltextzugriff (PDF)

Phase I studies of the novel carcinoembryonic antigen T-cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients (pts) with metastatic colorectal cancer (mCRC)

Annals of oncology, 2017-09, Vol.28, p.v134-v134

2017

Volltextzugriff (PDF)

LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2017-06, Vol.28 (suppl_3)

2017

Volltextzugriff (PDF)

Preclinical studies of PF-04849285, an interferon- alpha 8 fusion protein for the treatment of HCV

Antiviral therapy, 2012-01, Vol.17 (5), p.869-881

2012

Volltextzugriff (PDF)

How the sialylation level of serum N-acetyl-β-D-glucosAMinidase A form in Type 1 diabetes mellitus influences their activity?

Journal of the Serbian Chemical Society, 2014-01, Vol.79 (12), p.1491

2014

Volltextzugriff (PDF)

Dietary Fat Intake as Risk Factor for the Development of Diabetes

Diabetes care, 2003-02, Vol.26 (2), p.302-307

2003

Volltextzugriff (PDF)

ESTUDOS EM ANDAMENTO FASE IB E IIA: CROSSWALK-A E CROSSWALK-C, RANDOMIZADOS E CONTROLADOS POR PLACEBO - CROVALIMABE NO TRATAMENTO E PREVENÇÃO DE EPISÓDIOS VASO-OCLUSIVOS NA DOENÇA FALCIFORME

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S75-S76

2023

Volltextzugriff (PDF)

Preface: Astrophysical spectroscopy and atomic data applications

Advances in space research, 2023-01, Vol.71 (2), p.1217-1218

2023

Volltextzugriff (PDF)

Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study

Neurology, 2020-01, Vol.94 (4), p.e337

2020

Volltextzugriff (PDF)

1 – 25 von 775

Suche als RSS-Feed

Aktive Filter

KollektionWiley-Blackwell Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(564)
Mit Volltextzugriff
(637)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(380)
Physical Sciences
(182)
Life Sciences & Biomedicine
(151)
Physics
(111)
Technology
(95)
Humans
(75)
Exact Sciences And Technology
(55)
Male
(55)
Astronomy & Astrophysics
(50)
Female
(48)
Materials Science
(47)
General & Internal Medicine
(43)
Medicine, General & Internal
(43)
Optics
(36)
Physics, Atomic, Molecular & Chemical
(36)
Chemistry
(34)
Plasmas
(34)
Atomic Data
(33)
Social Sciences
(28)
Materials Science, Multidisciplinary
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(21)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Increased Oxidized High-Density Lipoprotein/High-Density Lipoprotein–Cholesterol Ratio as a Potential Indicator of Disturbed Metabolic Health in Overweight and Obese Individuals

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION

Characterisation of dietary fibre components in cereals and legumes used in Serbian diet

Effects of total fibre or resistant starch-rich diets within lifestyle intervention in obese prediabetic adults

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study

Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series

P838 Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study

Dietary fat intake as risk factor for the development of Diabetes: Multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD)

Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trial

P497 Is mucosal healing sufficient paramater for anti-TNF discontinuation?

P957 Subcutaneous infliximab (CT-P13 SC) for ulcerative colitis: 2-year extension results of the LIBERTY-UC study

P492 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study

ESTUDOS EM ANDAMENTO FASE IB E IIA: CROSSWALK-A E CROSSWALK-C, RANDOMIZADOS E CONTROLADOS POR PLACEBO - CROVALIMABE NO TRATAMENTO E PREVENÇÃO DE EPISÓDIOS VASO-OCLUSIVOS NA DOENÇA FALCIFORME

POS-052 TWO PHASE III TRIALS EVALUATING CROVALIMAB IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): COMMUTE-a and COMMUTE-p

Phase I studies of the novel carcinoembryonic antigen T-cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients (pts) with metastatic colorectal cancer (mCRC)

LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Preclinical studies of PF-04849285, an interferon- alpha 8 fusion protein for the treatment of HCV

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery

How the sialylation level of serum N-acetyl-β-D-glucosAMinidase A form in Type 1 diabetes mellitus influences their activity?

Dietary Fat Intake as Risk Factor for the Development of Diabetes

ESTUDOS EM ANDAMENTO FASE IB E IIA: CROSSWALK-A E CROSSWALK-C, RANDOMIZADOS E CONTROLADOS POR PLACEBO - CROVALIMABE NO TRATAMENTO E PREVENÇÃO DE EPISÓDIOS VASO-OCLUSIVOS NA DOENÇA FALCIFORME

Preface: Astrophysical spectroscopy and atomic data applications

Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study

Aktive Filter

Suchergebnisse filtern